LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "thrombotic stroke" as a keyword



Proteomics and the Risk of Incident Embolic and Thrombotic Stroke

Sign Up to like & get
recommendations! Published in 2025 at "Annals of Neurology"

DOI: 10.1002/ana.70011

Abstract: Personalized approaches to ischemic stroke diagnosis are needed. We determine differences in proteomic signatures of incident embolic (EIS) and thrombotic stroke (TIS) by age and resultant pathways using large‐scale proteomics. read more here.

Keywords: incident embolic; embolic thrombotic; risk incident; thrombotic stroke ... See more keywords

Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies

Sign Up to like & get
recommendations! Published in 2025 at "Journal of Thrombosis and Thrombolysis"

DOI: 10.1007/s11239-025-03093-3

Abstract: The P2Y12 receptor inhibitor prasugrel was approved for thrombotic stroke in Japan following the phase 3 clinical trials PRASTRO-I, -II, and -III. However, correlations between elevated platelet reaction unit (PRU) and ischemic event risk remain… read more here.

Keywords: prasugrel clopidogrel; analysis prastro; thrombotic stroke; pru ... See more keywords

Prasugrel for Secondary Prevention of Thrombotic Stroke

Sign Up to like & get
recommendations! Published in 2022 at "Journal of Atherosclerosis and Thrombosis"

DOI: 10.5551/jat.ed213

Abstract: It is widely accepted that antiplatelet therapy, especially therapy using thienopyridine derivatives, is effective for the secondary prevention of thrombotic stroke1, 2). Thienopyridine derivatives have been reported to significantly reduce recurrent ischemic stroke in patients… read more here.

Keywords: thrombotic stroke; secondary prevention; prasugrel; stroke ... See more keywords

Arterial and venous thrombotic stroke after ChAdOx1 nCoV-19 vaccine.

Sign Up to like & get
recommendations! Published in 2022 at "Clinical medicine"

DOI: 10.7861/clinmed.2021-0321

Abstract: Vaccine-induced thrombosis with thrombocytopenia (VITT) is a recently-described condition associated with arterial and venous thrombosis following vaccination with the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. This report describes two cases of stroke caused by arterial and venous… read more here.

Keywords: thrombotic stroke; chadox1 ncov; venous thrombotic; stroke chadox1 ... See more keywords